Lightnews — Scholar-powered news

Reposted by Michael S. Balzer

Physalia-courses@Online @physaliacourses.bsky.social · 2d

🚀 Curious about #SpatialOmics? Want to master spatial omics data analysis using #Rstats and @bioconductor.bsky.social ?

🔥 Registrations are now OPEN for the 3rd edition of our hands-on course with @stemang.bsky.social !

📅 Save the dates: 18–20 May 2026
www.physalia-courses.org/courses-work...

spatial Omics in R/Bioconductor

18-20 May 2026 To foster international participation, this course will be held online

www.physalia-courses.org

1 2

Michael S. Balzer @ms-balzer.bsky.social · Sep 4

Thx, Rebecca!

Michael S. Balzer @ms-balzer.bsky.social · Sep 4

Thanks, Tilo! 👍

Michael S. Balzer @ms-balzer.bsky.social · Sep 4

💯👍

Michael S. Balzer @ms-balzer.bsky.social · Sep 4

Thanks, Lennard! 🙏

Michael S. Balzer @ms-balzer.bsky.social · Sep 4

🚀Excited to announce that I’ve been awarded an @erc.europa.eu StG to advance research how kidneys heal themselves — a paradigm shift for understanding & treating #kidneydisease 🫘🩺🧬🧪
👉ERC press release: t.ly/CBxwB
👉Charité press release: t.ly/SR_Wn
#ERCStG #HorizonEU #KidneyResearch #NephSky #MedSky

The ERC awards €761m to the next generation of scientists in Europe

The European Research Council (ERC) has selected 478 early-career researchers across Europe to receive this year’s Starting Grants. With a total funding of €761 million, these grants support excellent...

t.ly

5 2 21

Reposted by Michael S. Balzer

Kidney Precision Medicine Project @kpmproject.bsky.social · Aug 15

📑 Need something to read this weekend? If so, you're in luck!

"Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules" fueled by #KPMP investigators is hot off the press today @science.org

www.science.org/doi/10.1126/...

Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules

The interplay in expression of the stem cell markers THY1 and PROM1 in kidney proximal tubules marks the timeline of disease.

www.science.org

4 12

Michael S. Balzer @ms-balzer.bsky.social · Aug 8

🔥 Huge congrats to @ksusztak.bsky.social & team on a landmark @natgenet.nature.com paper!
🚶‍♂️🐁🐀Cross-species 🫘kidney pathway dysregulation via #singlecell functional profiling of individual samples — opening new therapeutic avenues.
🔗 www.nature.com/articles/s41...
🧪 #NephSky #MedSky

1 7 17

Michael S. Balzer @ms-balzer.bsky.social · Jul 20

🔥Paper alert @nature.com. Fantastic 🧪resource for the renal 🫘 community! #NephSky #MedSky

Congrats @puellesv.bsky.social lab and team!

Pablo J. Sáez @pjsaez.bsky.social · Jul 18

#HotFromThePress !!

What if instead of analyzing 4-6 pathology markers you could check >100 in the *same* sample?

@maltekuehl.com & co @puellesv.bsky.social lab introduce #PathoPlex, method that could even predict disease

Full www.nature.com/articles/s41...
@focalplane.bsky.social @nature.com 🧪🔬

1 1 15

Reposted by Michael S. Balzer

Nature Reviews Nephrology @natrevneph.nature.com · Jul 18

Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup

Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.

www.nature.com

6 9

Reposted by Michael S. Balzer

Kidney International @kidneyint.bsky.social · Jul 7

Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy

doi.org/10.1016/j.kint.2025.05.028

#OpenAccess #IgAN #felzartamab #IgANephropathy

7 7

Reposted by Michael S. Balzer

JTKidney @jtkidney.bsky.social · Jul 5

Simon Davies kicking off day 2 of the 1st International Meeting on
Cellular and Molecular Peritonial Dialysis Research in Kiel.

1 4

Michael S. Balzer @ms-balzer.bsky.social · Jul 1

👏Congrats to the KidneyCure 2025 Grant Recipients! 🫘🧪
@asnpublications.bsky.social #NephSky #MedSky

1 7

Reposted by Michael S. Balzer

NEJM.org @nejm.org · Jun 21

In the latest video in our partnership with @glaucomflecken.bsky.social, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free: nej.md/DrG19

3 31 86

Reposted by Michael S. Balzer

ISPD - International Society for Peritoneal Dialysis @ispd.org · Jun 22

The Fellowship Program is one of the ISPD’s key instruments to strengthen global PD expertise through hands-on learning and knowledge exchange.

Learn more about the results of our first call for applications in 2025 and the new application modality for teams Doctor-Nurse.

buff.ly/7XjuPCM

ISPD Fellowship results - 1st call 2025 - International Society for Peritoneal Dialysis

The Fellowship Program is one of the ISPD’s key programs to strengthen global PD expertise through hands-on learning and knowledge exchange. For the first round of 2025, we received 17…

buff.ly

1 1

Michael S. Balzer @ms-balzer.bsky.social · Jun 7

Go Nina! Love the fancy ambience.

1 1

Reposted by Michael S. Balzer

NEJM.org @nejm.org · Jun 5

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology

A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.

1 16 29

Michael S. Balzer @ms-balzer.bsky.social · Jun 6

Go Braunschweig! 🫘

2

Michael S. Balzer @ms-balzer.bsky.social · Jun 4

🎉🎈Congrats to all ASN 2025 🏆Lifetime & Midcareer awardees!

Well-deserved, @ksusztak.bsky.social @rkramann.bsky.social @genetickidneydoc.bsky.social, you are on 🔥!!!
#NephSky, #MedSky, #ERA25

2 2 12

Reposted by Michael S. Balzer

ASN Publications @asnpublications.bsky.social · May 31

In the May 2025 #ASNKidneyNews Policy Update, explore recent new and existing policy actions from ASN Advocacy that benefit physicians, patients, and researchers. bit.ly/KN1705-16

1 2

Reposted by Michael S. Balzer

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · May 27

The effect of disappearing data from US public health

#OpenAccess viewpoint in @thelancet.com

www.thelancet.com/journals/lan...

#MedSky #EpiSky

Figure Full season (32-week-ahead) forecasts of influenza hospitalisations in the USA

2 8

Michael S. Balzer @ms-balzer.bsky.social · May 18

📣Attention #NephSky #MedSky!
Inaugural #PeritonealDialysis 🧪research meeting incoming:

"1st International Meeting on Cellular & Molecular #PD Research"
📆July 4-5, 2025 @The Nucleus, 🛳️Kiel, Germany
🔗Program & registration: www.pdmeeting.skip-sh.de
👫@ispd.org @dgfn.bsky.social ERA/EDTA

Program & registration: http://www.pdmeeting.skip-sh.de

2

Reposted by Michael S. Balzer

ASNKidney @asnkidney.bsky.social · May 7

⏳ Two Weeks Left! Submit your research abstract or case report for #KidneyWk 2025 by Wednesday, May 21, at 2:00 p.m. EDT.

Take the stage at the world’s premier nephrology meeting and share your work with 12,000+ kidney professionals.

Submit now: asn.kdny.info/SwgN50VMhU6

2 4

Reposted by Michael S. Balzer

Kidney International @kidneyint.bsky.social · May 5

Fluoroscopic repositioning of Tenckhoff catheter

doi.org/10.1016/j.kint.2024.09.027

#KINephrologyImage #NephSky #MedSky #peritonealdialysis

2 4

Reposted by Michael S. Balzer

Broad Institute @broadinstitute.org · Apr 3

A new spatial transcriptomics approach eliminates the need for time-intensive imaging with specialized equipment, making the technique accessible to more researchers around the world. @naturebiotech.bsky.social

Scientists have developed a way to scale up spatial genomics and lower costs

A new computational approach eliminates time-intensive imaging, enabling high-resolution spatial mapping of gene expression in tissue.

broad.io

3 8 28